Pharma Business review is using cookies

ContinueLearn More
Close
August 20, 2018

AbbVie, Tolero to collaborate on acute myeloid leukemia trial

AbbVie has entered into clinical research collaboration with Tolero Pharmaceuticals to assess the potential benefits of venetoclax and alvocidib combination in relapsed/refractory acute myeloid leukemia (AML).

Image: AbbVie corporate headquarters. Photo: courtesy of AbbVie Inc.